Update on the public tender offer by Camlin Fine Sciences

The Indian group Camlin Fine Sciences Limited (CFSL) has acquired a majority stake in Vinpai, representing 83.82% of the share capital and 80.86% of the voting rights. The simplified public tender offer for the remaining Vinpai shares, announced in December 2025 at a price of €3.60 per share, has been postponed to early May 2026. This postponement is due to administrative constraints related to Indian regulations and the need to include Vinpai's 2025 annual accounts in the documentation to be submitted to the AMF (French Financial Markets Authority).

CFSL, aiming to strengthen its European presence, no longer plans to withdraw Vinpai from the Euronext Growth listing, thus maintaining visibility and supporting future developments in Europe.